Creative Price To Sales Ratio vs Ev To Sales Analysis

CELZ Stock  USD 2.48  0.04  1.64%   
Creative Medical financial indicator trend analysis is way more than just evaluating Creative Medical Tec prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Creative Medical Tec is a good investment. Please check the relationship between Creative Medical Price To Sales Ratio and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Creative Medical Tec Price To Sales Ratio account and Ev To Sales. At this time, the significance of the direction appears to have strong relationship.
The correlation between Creative Medical's Price To Sales Ratio and Ev To Sales is 0.71. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Creative Medical Technology, assuming nothing else is changed. The correlation between historical values of Creative Medical's Price To Sales Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Creative Medical Technology are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Price To Sales Ratio i.e., Creative Medical's Price To Sales Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.71
Relationship DirectionPositive 
Relationship StrengthSignificant

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Creative Medical Tec stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Creative Medical sales, a figure that is much harder to manipulate than other Creative Medical Technology multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.
Most indicators from Creative Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Creative Medical Tec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creative Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Creative Medical's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 3.7 M in 2025, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2025.
 2021 2024 2025 (projected)
Reconciled Depreciation92.1K105.9K64.0K
Depreciation And Amortization92.1K108.8K57.6K

Creative Medical fundamental ratios Correlations

-0.150.6-0.780.74-0.870.860.510.94-0.151.0-0.27-0.850.841.00.88-0.43-0.43-0.19-0.220.660.570.65-0.590.590.65
-0.15-0.87-0.430.050.16-0.160.33-0.031.0-0.170.660.13-0.09-0.17-0.160.610.611.00.83-0.820.340.52-0.340.360.53
0.6-0.87-0.030.35-0.540.530.020.47-0.870.62-0.66-0.550.510.620.54-0.7-0.7-0.9-0.770.980.0-0.11-0.010.0-0.11
-0.78-0.43-0.03-0.50.72-0.75-0.47-0.88-0.43-0.76-0.170.54-0.55-0.76-0.71-0.03-0.04-0.39-0.29-0.14-0.79-0.940.81-0.84-0.94
0.740.050.35-0.5-0.540.390.90.520.050.74-0.05-0.910.920.740.54-0.13-0.12-0.03-0.020.290.440.43-0.440.430.43
-0.870.16-0.540.72-0.54-0.96-0.31-0.890.16-0.880.260.57-0.56-0.87-0.990.410.40.190.22-0.65-0.49-0.530.51-0.51-0.52
0.86-0.160.53-0.750.39-0.960.150.94-0.160.86-0.26-0.480.470.860.97-0.42-0.41-0.18-0.210.670.50.58-0.540.540.57
0.510.330.02-0.470.9-0.310.150.330.330.510.03-0.740.770.510.30.190.190.250.28-0.050.410.51-0.410.480.51
0.94-0.030.47-0.880.52-0.890.940.33-0.030.93-0.16-0.640.630.930.9-0.3-0.29-0.06-0.10.590.660.76-0.70.710.76
-0.151.0-0.87-0.430.050.16-0.160.33-0.03-0.170.660.13-0.09-0.17-0.160.610.611.00.83-0.820.340.52-0.340.360.53
1.0-0.170.62-0.760.74-0.880.860.510.93-0.17-0.28-0.860.851.00.88-0.45-0.45-0.22-0.240.680.550.63-0.580.570.63
-0.270.66-0.66-0.17-0.050.26-0.260.03-0.160.66-0.280.24-0.2-0.28-0.260.60.60.660.48-0.640.320.15-0.320.240.15
-0.850.13-0.550.54-0.910.57-0.48-0.74-0.640.13-0.860.24-1.0-0.86-0.570.40.390.190.23-0.5-0.39-0.470.4-0.39-0.47
0.84-0.090.51-0.550.92-0.560.470.770.63-0.090.85-0.2-1.00.850.56-0.34-0.33-0.16-0.180.460.440.5-0.430.440.5
1.0-0.170.62-0.760.74-0.870.860.510.93-0.171.0-0.28-0.860.850.88-0.45-0.45-0.22-0.240.680.550.63-0.580.570.63
0.88-0.160.54-0.710.54-0.990.970.30.9-0.160.88-0.26-0.570.560.88-0.41-0.4-0.2-0.220.660.470.52-0.510.50.52
-0.430.61-0.7-0.03-0.130.41-0.420.19-0.30.61-0.450.60.4-0.34-0.45-0.411.00.590.8-0.710.370.2-0.370.410.21
-0.430.61-0.7-0.04-0.120.4-0.410.19-0.290.61-0.450.60.39-0.33-0.45-0.41.00.590.8-0.70.390.21-0.380.420.22
-0.191.0-0.9-0.39-0.030.19-0.180.25-0.061.0-0.220.660.19-0.16-0.22-0.20.590.590.81-0.840.290.49-0.290.310.49
-0.220.83-0.77-0.29-0.020.22-0.210.28-0.10.83-0.240.480.23-0.18-0.24-0.220.80.80.81-0.740.470.47-0.470.460.47
0.66-0.820.98-0.140.29-0.650.67-0.050.59-0.820.68-0.64-0.50.460.680.66-0.71-0.7-0.84-0.740.07-0.01-0.090.08-0.01
0.570.340.0-0.790.44-0.490.50.410.660.340.550.32-0.390.440.550.470.370.390.290.470.070.82-0.970.950.82
0.650.52-0.11-0.940.43-0.530.580.510.760.520.630.15-0.470.50.630.520.20.210.490.47-0.010.82-0.820.891.0
-0.59-0.34-0.010.81-0.440.51-0.54-0.41-0.7-0.34-0.58-0.320.4-0.43-0.58-0.51-0.37-0.38-0.29-0.47-0.09-0.97-0.82-0.95-0.82
0.590.360.0-0.840.43-0.510.540.480.710.360.570.24-0.390.440.570.50.410.420.310.460.080.950.89-0.950.89
0.650.53-0.11-0.940.43-0.520.570.510.760.530.630.15-0.470.50.630.520.210.220.490.47-0.010.821.0-0.820.89
Click cells to compare fundamentals

Creative Medical Account Relationship Matchups

Creative Medical fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets717.8K11.3M19.2M10.7M12.3M12.9M
Total Current Liabilities40.5M1.1M3.3M371.4K427.1K405.7K
Total Stockholder Equity(39.8M)10.2M15.9M10.3M9.3M9.8M
Retained Earnings(61.9M)(43.7M)(53.8M)(59.1M)(53.2M)(50.5M)
Accounts Payable350.9K761.9K3.3M317.3K364.9K370.6K
Net Receivables5.6K0.02.5K(10.1M)(9.1M)(8.6M)
Common Stock Shares Outstanding57.9K324.9K1.1M1.4M1.6M1.7M
Liabilities And Stockholders Equity717.8K11.3M19.2M10.7M12.3M12.9M
Other Stockholder Equity21.3M53.9M69.7M69.4M79.9M83.8M
Total Liab40.5M1.1M3.3M371.4K427.1K405.7K
Total Current Assets98.0K10.7M18.7M10.3M11.8M12.4M
Common Stock768.5K6.3K14.1K1.4K1.6K1.6K
Net Debt690.7K(10.7M)(18.4M)(3.5M)(3.1M)(3.0M)
Cash98.0K10.7M18.4M3.5M4.0M2.2M
Cash And Short Term Investments98.0K10.7M18.4M10.0M11.5M12.1M
Short Long Term Debt Total682.1K1.1M788.7K14.2K16.3K15.5K
Short Term Debt682.1K1.1M788.7K14.2K16.3K15.5K
Other Current Liab6.8M39.4M288.6K54.1K62.2K59.1K
Current Deferred Revenue10.8K371.4K639.4K(14.2K)(16.3K)(15.5K)
Net Tangible Assets(8.5M)(40.4M)9.7M15.4M17.7M18.6M
Non Current Assets Total619.8K531.0K438.9K444.3K510.9K401.4K
Non Currrent Assets Other163.5K(436.6K)(619.8K)3.3K3.0K3.1K
Intangible Assets619.8K527.7K435.6K441.0K507.2K400.0K
Net Invested Capital(39.0M)10.2M15.9M10.3M11.9M12.5M
Net Working Capital(40.4M)9.7M15.4M9.9M11.4M12.0M
Capital Stock771.5K6.3K14.1K1.4K1.3K1.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.